Green Alpha Advisors, LLC

Position in BEAM — Beam Therapeutics Inc.

CIK 1439207 NIWOT, CO

Position in BEAM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$259,768

+$23,677 QoQ

Shares Held

7,569

-11.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#177

of 274 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Green Alpha Advisors, LLC holds $9,323,372 across 14 Biotechnology names. BEAM ranks #8 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	55,804	$3,043,550
2	MRNA	Moderna, Inc.	33,758	$2,364,072
3	PRME	Prime Medicine, Inc.	185,023	$682,734
4	CRBU	Caribou Biosciences, Inc.	364,324	$641,210
5	RXRX	Recursion Pharmaceuticals, Inc.	147,544	$541,486
6	EDIT	Editas Medicine, Inc.	156,046	$505,589
7	VRTX	Vertex Pharmaceuticals Inc / Ma	552	$274,194
8	BEAM	Beam Therapeutics Inc. This page	7,569	$259,768

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$259,768	7,569	-11.1%	Shares	Sole	2026-08-11
2025-12-31	$236,091	8,517	-16.4%	Shares	Sole	2026-01-07
2024-12-31	$252,761	10,192	-18.3%	Shares	Sole	2025-01-13
2024-09-30	$305,637	12,475	+5.9%	Shares	Sole	2024-10-07
2024-06-30	$275,935	11,777	-13.6%	Shares	Sole	2024-08-13
2024-03-31	$450,533	13,636	-2.0%	Shares	Sole	2024-04-10
2023-12-31	$378,602	13,909	-10.7%	Shares	Sole	2024-01-05
2023-09-30	$374,554	15,574	+24.7%	Shares	Sole	2023-10-10
2023-06-30	$398,837	12,491	+21.7%	Shares	Sole	2023-07-06
2023-03-31	$314,222	10,262	-0.3%	Shares	Sole	2023-04-06
2022-12-31	$402,441	10,290	+4.8%	Shares	Sole	2023-01-12
2022-09-30	$467,967	9,823	+0.6%	Shares	Sole	2022-10-14
2022-06-30	$378,157	9,769	—	Shares	Sole	2022-07-08
No filing history on record for this holder in this stock.